U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412938) titled 'JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study' on Jan. 26.
Brief Summary: This first-in-human, single-center study in China evaluated the safety, tolerability, and pharmacokinetics of single oral doses of JKN2306 tablets in healthy adult subjects and assessed the effect of a high-fat, high-calorie meal on the pharmacokinetics of JKN2306.
Study Start Date: Feb. 12, 2025
Study Type: INTERVENTIONAL
Condition:
Acute Pain
Intervention:
DRUG: JKN2306
JKN2306 tablet, oral
DRUG: Placebo
matching placebo tablet
Recruitment Status: COMPLETED
Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd
Publis...